These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 23541266)

  • 21. Is non-HDL-cholesterol a better predictor of long-term outcome in patients after acute myocardial infarction compared to LDL-cholesterol? : a retrospective study.
    Wongcharoen W; Sutthiwutthichai S; Gunaparn S; Phrommintikul A
    BMC Cardiovasc Disord; 2017 Jan; 17(1):10. PubMed ID: 28056802
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Predictive value of lipoprotein indices for residual risk of acute myocardial infarction and sudden death in men with low-density lipoprotein cholesterol levels <120 mg/dl.
    Tanaka F; Makita S; Onoda T; Tanno K; Ohsawa M; Itai K; Sakata K; Omama S; Yoshida Y; Ogasawara K; Ogawa A; Ishibashi Y; Kuribayashi T; Okayama A; Nakamura M;
    Am J Cardiol; 2013 Oct; 112(8):1063-8. PubMed ID: 23831165
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Usefulness of plasma matrix metalloproteinase-9 level in predicting future coronary revascularization in patients after acute myocardial infarction.
    Wang KF; Huang PH; Chiang CH; Hsu CY; Leu HB; Chen JW; Lin SJ
    Coron Artery Dis; 2013 Jan; 24(1):23-8. PubMed ID: 23151854
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Rosuvastatin-induced high-density lipoprotein changes in patients who underwent percutaneous coronary intervention for non-ST-segment elevation acute coronary syndrome.
    Yun KH; Shin SN; Ko JS; Rhee SJ; Kim NH; Oh SK; Jeong JW
    J Cardiol; 2012 Nov; 60(5):383-8. PubMed ID: 22884684
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Benefit of early statin therapy in patients with acute myocardial infarction who have extremely low low-density lipoprotein cholesterol.
    Lee KH; Jeong MH; Kim HM; Ahn Y; Kim JH; Chae SC; Kim YJ; Hur SH; Seong IW; Hong TJ; Choi DH; Cho MC; Kim CJ; Seung KB; Chung WS; Jang YS; Rha SW; Bae JH; Cho JG; Park SJ;
    J Am Coll Cardiol; 2011 Oct; 58(16):1664-71. PubMed ID: 21982310
    [TBL] [Abstract][Full Text] [Related]  

  • 26. High-density lipoprotein cholesterol levels and cardiovascular outcomes in Japanese patients after percutaneous coronary intervention: a report from the CREDO-Kyoto registry cohort-2.
    Izuhara M; Ono K; Shiomi H; Morimoto T; Furukawa Y; Nakagawa Y; Shizuta S; Tada T; Tazaki J; Horie T; Kuwabara Y; Baba O; Nishino T; Kita T; Kimura T;
    Atherosclerosis; 2015 Oct; 242(2):632-8. PubMed ID: 26022139
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Relation between paradoxical decrease in high-density lipoprotein cholesterol levels after statin therapy and adverse cardiovascular events in patients with acute myocardial infarction.
    Ota T; Ishii H; Suzuki S; Tanaka A; Shibata Y; Tatami Y; Harata S; Shimbo Y; Takayama Y; Kawamura Y; Osugi N; Maeda K; Kondo T; Murohara T
    Am J Cardiol; 2015 Feb; 115(4):411-6. PubMed ID: 25555656
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Association between lipid levels and major adverse cardiovascular events in rheumatoid arthritis compared to non-rheumatoid arthritis patients.
    Liao KP; Liu J; Lu B; Solomon DH; Kim SC
    Arthritis Rheumatol; 2015 May; 67(8):2004-10. PubMed ID: 25917955
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Utility of lipoprotein-associated phospholipase A2 for prediction of 30-day major adverse coronary event in patients with the first anterior ST-segment elevation myocardial infarction treated by primary percutaneous coronary intervention.
    Stankovic S; Asanin M; Trifunovic D; Majkic-Singh N; Miljković A; Ignjatovic S; Mrdovic I; Matic D; Savic L; Ostojic M; Vasiljevic Z
    Clin Lab; 2012; 58(11-12):1135-44. PubMed ID: 23289182
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Relationship of high-density lipoprotein cholesterol with periprocedural myocardial injury following elective percutaneous coronary intervention in patients with low-density lipoprotein cholesterol below 70 mg/dL.
    Li XL; Guo YL; Zhu CG; Xu RX; Qing P; Wu NQ; Jiang LX; Xu B; Gao RL; Li JJ
    J Am Heart Assoc; 2015 Jan; 4(1):e001412. PubMed ID: 25572484
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Low plasma HDL-c, a vascular risk factor in high risk patients independent of LDL-c.
    Hajer GR; van der Graaf Y; Bots ML; Algra A; Visseren FL;
    Eur J Clin Invest; 2009 Aug; 39(8):680-8. PubMed ID: 19453647
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Elevated Serum Non-HDL (High-Density Lipoprotein) Cholesterol and Triglyceride Levels as Residual Risks for Myocardial Infarction Recurrence Under Statin Treatment.
    Suzuki K; Oikawa T; Nochioka K; Miura M; Kasahara S; Sato M; Aoyanagi H; Shiroto T; Takahashi J; Miyata S; Sakata Y; Shimokawa H
    Arterioscler Thromb Vasc Biol; 2019 May; 39(5):934-944. PubMed ID: 30866657
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Impact of low-density lipoprotein cholesterol/high-density lipoprotein cholesterol ratio on long-term outcome in patients undergoing percutaneous coronary intervention.
    Matsumoto I; Miyake Y; Mizukawa M; Takagi Y
    Circ J; 2011; 75(4):905-10. PubMed ID: 21325724
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Low-Density Lipoprotein Cholesterol, Non-High-Density Lipoprotein Cholesterol, Triglycerides, and Apolipoprotein B and Cardiovascular Risk in Patients With Manifest Arterial Disease.
    van den Berg MJ; van der Graaf Y; de Borst GJ; Kappelle LJ; Nathoe HM; Visseren FLJ;
    Am J Cardiol; 2016 Sep; 118(6):804-810. PubMed ID: 27471056
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Long-term effects of drug-eluting stents versus bare metal stents on patients with acute ST-elevation myocardial infarction undergoing primary percutaneous coronary intervention: outcomes of 3-year clinical follow-up.
    Wang CH; Fang Q; Zhang SY; Shen ZJ; Fan ZJ; Jin XF; Zeng Y; Liu ZY; Xie HZ; Yang M
    Chin Med J (Engl); 2012 Aug; 125(16):2803-6. PubMed ID: 22932070
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Low-density lipoprotein cholesterol level in patients with acute myocardial infarction having percutaneous coronary intervention (the cholesterol paradox).
    Cho KH; Jeong MH; Ahn Y; Kim YJ; Chae SC; Hong TJ; Seong IW; Chae JK; Kim CJ; Cho MC; Seung KB; Park SJ;
    Am J Cardiol; 2010 Oct; 106(8):1061-8. PubMed ID: 20920639
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Relative efficacy of atorvastatin 80 mg and pravastatin 40 mg in achieving the dual goals of low-density lipoprotein cholesterol <70 mg/dl and C-reactive protein <2 mg/l: an analysis of the PROVE-IT TIMI-22 trial.
    Ridker PM; Morrow DA; Rose LM; Rifai N; Cannon CP; Braunwald E
    J Am Coll Cardiol; 2005 May; 45(10):1644-8. PubMed ID: 15893181
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Hypertriglyceridemia and residual dyslipidemia in statin-treated, patients with diabetes at the highest risk for cardiovascular disease and achieving very-low low-density lipoprotein-cholesterol levels.
    Querton L; Buysschaert M; Hermans MP
    J Clin Lipidol; 2012; 6(5):434-42. PubMed ID: 23009779
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Relationship between serum low-density lipoprotein cholesterol and in-hospital mortality following acute myocardial infarction (the lipid paradox).
    Reddy VS; Bui QT; Jacobs JR; Begelman SM; Miller DP; French WJ;
    Am J Cardiol; 2015 Mar; 115(5):557-62. PubMed ID: 25727079
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Time dependent changes in high density lipoprotein cholesterol and cardiovascular risk.
    Milwidsky A; Kivity S; Kopel E; Klempfner R; Berkovitch A; Segev S; Sidi Y; Goldenberg I; Maor E
    Int J Cardiol; 2014 May; 173(2):295-9. PubMed ID: 24681020
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.